You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 107 No. 3, March 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICOPATHOLOGIC REPORTS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Malignant Melanoma of the Iris in Xeroderma Pigmentosum

Mark W. Johnson, MD; Gregory L. Skuta, MD; Marilyn C. Kincaid, MD; Christine C. Nelson, MD; J. Reimer Wolter, MD

Arch Ophthalmol. 1989;107(3):402-407.


Abstract



• Xeroderma pigmentosum is an autosomal recessive, precancerous dermatosis caused by defective repair of ultraviolet-damaged DNA. Characterized clinically by progressive cutaneous pigmentary alterations and tumorigenesis, it serves as a model for ultraviolet carcinogenesis. We describe the clinical and histopathologic findings in a 31-year-old woman with xeroderma pigmentosum and a massive iris melanoma of the left eye. Histologic examination following enucleation revealed diffuse iris replacement by spindle and epithelioid cells with extension into the trabecular meshwork. Evidence of direct extraocular extension was absent, and a metastatic evaluation showed no abnormalities. To our knowledge, this is the first reported case of xeroderma pigmentosum complicated by melanoma of the iris. It provides further evidence suggesting a role for sunlight exposure in the pathogenesis of uveal melanoma.



Author Affiliations



From the W. K. Kellogg Eye Center, the Departments of Ophthalmology (Drs Johnson, Skuta, Nelson, and Wolter) and Pathology (Dr Wolter), University of Michigan, Ann Arbor; and the Department of Pathology, Henry Ford Hospital, Detroit (Dr Kincaid).


Footnotes



Accepted for publication Sept 16, 1988.

Read in part before the Annual Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Fla, May 5, 1988.

Reprint requests to W. K. Kellogg Eye Center, 1000 Wall St, Ann Arbor, MI 48105 (Dr Skuta).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.